Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Consistency Of RQ-PCR Analysis Results In Peripheral Blood and Bone Marrow Samples In Chronic Myeloid Leukemia Patients: Relevance From The Practical and Logistic Point Of View

Giovanna Rege-Cambrin, Carmen Fava, MD, Enrico Gottardi, BD, Filomena Daraio, PhD, Emilia Giugliano, PhD, Francesca Crasto, Roberta Lorenzatti, Alessandro Volpengo, Bruno Di Gioacchino, Giuseppe Saglio

Blood (2013) 122 (21): 2592.

https://doi.org/10.1182/blood.V122.21.2592.2592

Published: 2013

Journal Articles

Cytoplasmic-Nuclear Shuttling of mTOR Protein in Multiple Myeloma Cell Lines and Primary Myeloma Cells: A New Mechanism Regulated by Pomalidomide

Tommasina Guglielmelli, MD, Emilia Giugliano, PhD, Vanessa Brunetto, PhD, Sokol Rrodhe, MD, Giuseppe Saglio, MD

Blood (2012) 120 (21): 4019.

https://doi.org/10.1182/blood.V120.21.4019.4019

Published: 2012

Journal Articles

SIRT1 Activator 3 Potently Induces Apoptosis in Multiple Myeloma Cell Lines and in Primary Human Multiple Myeloma Cells.

Tommasina Guglielmelli, MD, Emilia Giugliano, PhD, Ilaria Defilippi, PhD, Marisa Pautasso, MD, Roberta Merlini, MD, Vanessa Brunetto, PhD, Giuseppe Saglio

Blood (2009) 114 (22): 3845.

https://doi.org/10.1182/blood.V114.22.3845.3845

Published: 2009

Journal Articles

The AKT/mTOR/P70S6K/4EB-P1 Signaling Pathway Is Activated in a Subset of Multiple Myeloma Patients and Correlates with High Serum Levels of Beta2-Microglobulin

Tommasina Guglielmelli, MD, Susanna Cappia, MD, Emilia Giugliano, PhD, Roberta Merlini, MD, Elisa Bacillo, MD, Francesca Gay, MD, Paola Berchialla, PhD, Dario Gregori, PhD, Mauro Papotti, PhD, Antonio Palumbo, MD, Giuseppe Saglio, PhD

Blood (2008) 112 (11): 2716.

https://doi.org/10.1182/blood.V112.11.2716.2716

Published: 2008

Journal Articles

Identification of the Involvement of the Tyrosine Kinase C-Ros in the Pathogenesis of Chronic Myelomonocytic Leukemia (CMML)

Daniela Cilloni, MD, PhD, Sonia Carturan, PhD, Enrico Bracco, PhD, Ilaria Defilippi, PhD, Chiara Maffè, PhD, Ilaria Iacobucci, Marisa Pautasso, MD, Antonia Rotolo, Emilia Giugliano, PhD, Emanuela Messa, MD, Giovanni Martinelli, MD, Giuseppe Saglio, MD

Blood (2008) 112 (11): 687.

https://doi.org/10.1182/blood.V112.11.687.687

Published: 2008

Journal Articles

The Quantitative Assessment of WT1 Allows To Distinguish between Primary and Secondary or Reactive Hypereosinophilia.

Daniela Cilloni, MD, PhD, Francesca Messa, PhD, Giovanni Martinelli, MD, Enrico Gottardi, PhD, Ilaria Defilippi, PhD, Francesca Arruga, PhD, Sonia Carturan, PhD, Emanuela Messa, MD, Emilia Giugliano, PhD, Valentina Rosso, PhD, Serena Merante, MD, Annalisa Charenza, MD, Michela Rondoni, MD, Emanuela Ottaviani, PhD, Mario Tiribelli, MD, Fabrizio Pane, MD, Michele Baccarani, MD, Giuseppe Saglio, MD

Blood (2005) 106 (11): 3251.

https://doi.org/10.1182/blood.V106.11.3251.3251

Published: 2005

NARROW

Consistency Of RQ-PCR Analysis Results In Peripheral Blood and Bone Marrow Samples In Chronic Myeloid Leukemia Patients: Relevance From The Practical and Logistic Point Of View

Cytoplasmic-Nuclear Shuttling of mTOR Protein in Multiple Myeloma Cell Lines and Primary Myeloma Cells: A New Mechanism Regulated by Pomalidomide

SIRT1 Activator 3 Potently Induces Apoptosis in Multiple Myeloma Cell Lines and in Primary Human Multiple Myeloma Cells.

The AKT/mTOR/P70S6K/4EB-P1 Signaling Pathway Is Activated in a Subset of Multiple Myeloma Patients and Correlates with High Serum Levels of Beta2-Microglobulin

Identification of the Involvement of the Tyrosine Kinase C-Ros in the Pathogenesis of Chronic Myelomonocytic Leukemia (CMML)

The Quantitative Assessment of WT1 Allows To Distinguish between Primary and Secondary or Reactive Hypereosinophilia.

Email alerts

ASH Publications

American Society of Hematology

Consistency Of RQ-PCR Analysis Results In Peripheral Blood and Bone Marrow Samples In Chronic Myeloid Leukemia Patients: Relevance From The Practical and Logistic Point Of View

Cytoplasmic-Nuclear Shuttling of mTOR Protein in Multiple Myeloma Cell Lines and Primary Myeloma Cells: A New Mechanism Regulated by Pomalidomide

SIRT1 Activator 3 Potently Induces Apoptosis in Multiple Myeloma Cell Lines and in Primary Human Multiple Myeloma Cells.

The AKT/mTOR/P70S6K/4EB-P1 Signaling Pathway Is Activated in a Subset of Multiple Myeloma Patients and Correlates with High Serum Levels of Beta2-Microglobulin

Identification of the Involvement of the Tyrosine Kinase C-Ros in the Pathogenesis of Chronic Myelomonocytic Leukemia (CMML)

The Quantitative Assessment of WT1 Allows To Distinguish between Primary and Secondary or Reactive Hypereosinophilia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only